Health Linkages uses a combination of blockchain and big data technologies to allow organizations to trust, protect and share their data. Brennan Bennett is the founder of Blockchain Healthcare Review, a publication covering blockchain technology innovation through the lens of health informatics.Tags: Grant Proposal Cover LetterHow To Write An Effective Literature ReviewMaths Problems SolvingWrite Economic Thesis PaperStanford University Opencourseware1994 Ap Literature EssayPreparing For Final Dissertation DefenseEssay Building Nation
Her company has implemented a Blockchain Identity Translation (BIT) platform and SDKs for system administrators and developers to manage user identities, strong multi-factor authentication, unification, delegation, consent directives, and portable identities to increase corporate trust on Blockchains.
Dawn currently sits on the Board of Directors at the OASIS Open international standards organization, and on the Board of the IWK Health Centre.
Alan serves as an advisor to several blockchain companies, including companies focused on blockchain transaction analysis, identity validation, enterprise blockchain applications, and device authentication for the Internet of Things.
Ken Cottrill is co-founder of Chain Business Insights and Research Principal.
He began at Spectrum in 2000 and has written about a range of topics including strange semiconductors, stimulators for psychiatric treatment, and the robotization of biotechnology.
He now guides the publication’s news operation and shared a Neal Award for Spectrum’s coverage of the Fukushima nuclear disaster.Alan counsels companies on cybersecurity, blockchain and distributed ledger technology, and national security issues.He previously served in senior policy and management positions at the US Department of Homeland Security for almost a decade, most recently as the Assistant Secretary for Strategy, Planning, Analysis & Risk and second-in-charge overall of the DHS Office of Policy.Currently Dave is Director of New Innovation and Technology at Amgen where he spends his time having fun with his team while leading the research and early adoption of transformative services and technologies such as developing Dev Ops frameworks, integration into public clouds, supporting serverless computing, and currently spending quality time with blockchain technologies in clinical trials and in supply chain.President, Ma CT USA IEEE P1451-99 Io T Harmonization, Chairman IEEE P21451-1- 4 (Sensei-Io T*), Chairman William Miller is President of Maximum Control Technologies (Ma CT) which is a MILLER W J & ASSOCIATES Company with offices in the United States and Canada,.And although GTP was not formed to be solely an IT services company, many of GTP’s biggest successes have had an IT component.Eric has managed project teams of more than 500 members with project budgets in excess of 0M USD. Garvin has spent the last 4 years leading serialization implementation programs, both for the US and globally.With a long history of working with State and Federal regulators, he also is currently working with the FDA on its Pilot Program to explore and evaluate ways to enhance the safety and security of the pharmaceutical supply chain.Alan Cohn is Of Counsel at Steptoe & Johnson LLP, co-chair of the firm’s Blockchain and Digital Currency practice, and counsel to the Blockchain Alliance, a public-private forum for blockchain companies to engage with law enforcement and regulatory agencies.His ability to harness this expertise to innovate around complex challenges has made him a trusted partner to industry in its ongoing efforts to implement track & trace, serialization and regulations. Celeste launched the Center for Supply Chain Studies (the Center) to continue his implementation of strategic simulation processes to address the ever-growing challenges and demands that face all stakeholders in the supply chain.With the recent launch of the Center’s first Reference Model-based Studies that examine the Drug Supply Chain Security Act (DSCSA) as it relates to a variety of subjects including master data management, blockchain technology and others, Bob continues to lead the way in industry exploration and education. Celeste was Senior Director at GS1 US where he worked with industry on standards-based, item-level traceability and was the lead in developing the pharma supply chain simulation model for DSCSA, as well as the comprehensive guideline for how to apply EPCIS for DSCSA requirements.